首页 › 基金 › Frazier Life Sciences Management, L.P. › ERAS
Frazier Life Sciences Management, L.P. 对 ERAS 的持仓历史
ERASCA INC · 医疗保健
Frazier Life Sciences Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 ERAS(ERASCA INC)24,975,188 股,市值约 US$457.5M,约占其申报组合的 9.96%,在其申报持仓中市值排名第 3 位。 Frazier Life Sciences Management, L.P. 最近 9 个申报季度中有 9 个季度披露了 ERAS 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Frazier Life Sciences Management, L.P. 对 ERAS 的持仓演变
Frazier Life Sciences Management, L.P. 于 Q2 2024 首次披露 ERAS 持仓:16,216,216 股(约 US$38.3M)。 该持仓在 Q2 2026 达到峰值 24,975,188 股,市值约 US$457.5M。 在 9 次申报中,Frazier Life Sciences Management, L.P. 5 次增持、0 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 24,975,188 股、市值约 US$457.5M,环比增持 300,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 16.22M | $38.27M | 新进 |
| Q3 2024 | 19.39M | $52.94M | 增持 |
| Q4 2024 | 19.39M | $48.67M | 持有 |
| Q1 2025 | 22.58M | $30.93M | 增持 |
| Q2 2025 | 22.73M | $28.87M | 增持 |
| Q3 2025 | 22.73M | $49.55M | 持有 |
| Q4 2025 | 22.73M | $84.55M | 持有 |
| Q1 2026 | 24.68M | $399.24M | 增持 |
| Q2 2026 | 24.98M | $457.55M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ERAS 与 13F 数据
ERAS(ERASCA INC)属于医疗保健行业。我们追踪的基金中还有 78 只申报持有 ERAS,申报仓位最大的包括:RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M), Logos Global Management LP (US$222.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ERAS 的基金
- RTW INVESTMENTS, LP 17.95M 股 · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M 股 · $327.78M · Q2 2026
- Logos Global Management LP 12.15M 股 · $222.59M · Q2 2026
- Siren, L.L.C. 11.40M 股 · $208.81M · Q2 2026
- Paradigm Biocapital Advisors LP 9.55M 股 · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M 股 · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M 股 · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.25M 股 · $96.18M · Q2 2026
- Vivo Capital, LLC 4.13M 股 · $75.61M · Q2 2026
- a16z Capital Management, L.L.C. 2.86M 股 · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M 股 · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M 股 · $41.35M · Q2 2026
更多关于 Frazier Life Sciences Management, L.P.
常见问题
How long has Frazier Life Sciences Management, L.P. held ERAS?
Frazier Life Sciences Management, L.P. has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Frazier Life Sciences Management, L.P.'s current position in ERAS?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 24.98M shares of ERAS (ERASCA INC), valued at $457.55M, representing 9.96% of its reported portfolio and ranking #3.
Has Frazier Life Sciences Management, L.P. been buying or selling ERAS?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. increased its position in ERAS. The position peaked in Q2 2026 at 24.98M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include RTW INVESTMENTS, LP, Venrock Adviser, LLC, Logos Global Management LP, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.